Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6515 | 1406 | 39.4 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
754 | 11793 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DANISH NURSE COHORT | Address | 3 | 100% | 0% | 3 |
2 | EPES EPIDEMIOL | Address | 3 | 60% | 0% | 3 |
3 | BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST | Author keyword | 2 | 67% | 0% | 2 |
4 | BREAST TUMOR ABORAT STUDY | Address | 2 | 67% | 0% | 2 |
5 | CONTINUOUS INCUBATION | Author keyword | 2 | 67% | 0% | 2 |
6 | ESTROGEN DEFICIENCY SYMPTOMS | Author keyword | 2 | 67% | 0% | 2 |
7 | ESTROGEN ONLY THERAPY | Author keyword | 2 | 67% | 0% | 2 |
8 | MRC BHF CLIN TRIAL SERV UNIT | Address | 2 | 67% | 0% | 2 |
9 | RISK FACTORS FOR BREAST CANCER | Author keyword | 2 | 67% | 0% | 2 |
10 | STEROID CONCENTRATION | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MENOPAUSAL ESTROGEN | 47 | 66% | 3% | 44 |
2 | MENOPAUSAL ESTROGENS | 23 | 69% | 1% | 20 |
3 | EXOGENOUS ESTROGENS | 23 | 53% | 2% | 31 |
4 | PROGESTIN REPLACEMENT | 20 | 62% | 1% | 21 |
5 | DIFFERENT REGIMENS | 17 | 59% | 1% | 19 |
6 | EXPANDED CASE CONTROL | 15 | 88% | 0% | 7 |
7 | SCREENING MAMMOGRAPHY POPULATION | 15 | 88% | 0% | 7 |
8 | ESTROGEN PROGESTIN REPLACEMENT | 12 | 17% | 4% | 62 |
9 | POSTMENOPAUSAL CYNOMOLGUS MACAQUES | 8 | 75% | 0% | 6 |
10 | PROGESTIN REPLACEMENT THERAPY | 7 | 35% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lobular breast cancer: incidence and genetic and non-genetic risk factors | 2015 | 1 | 100 | 30% |
A METAANALYSIS OF THE EFFECT OF ESTROGEN REPLACEMENT THERAPY ON THE RISK OF BREAST-CANCER | 1991 | 538 | 43 | 63% |
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer | 2012 | 38 | 90 | 44% |
Breast cancer risk with postmenopausal hormonal treatment | 2005 | 78 | 70 | 63% |
Hormone replacement therapy and the risk of breast cancer | 2011 | 38 | 48 | 46% |
Hormone replacement therapy and breast cancer: A qualitative review | 2001 | 95 | 86 | 79% |
MENOPAUSAL HORMONE REPLACEMENT THERAPY AND BREAST-CANCER - A METAANALYSIS | 1992 | 172 | 46 | 70% |
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review | 2013 | 21 | 94 | 31% |
Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis | 2006 | 65 | 110 | 68% |
The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence | 2009 | 23 | 40 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DANISH NURSE COHORT | 3 | 100% | 0.2% | 3 |
2 | EPES EPIDEMIOL | 3 | 60% | 0.2% | 3 |
3 | BREAST TUMOR ABORAT STUDY | 2 | 67% | 0.1% | 2 |
4 | MRC BHF CLIN TRIAL SERV UNIT | 2 | 67% | 0.1% | 2 |
5 | ENDOCRINOL MENOPAUSE | 1 | 19% | 0.5% | 7 |
6 | FRENCH MULTI BREAST STUDY | 1 | 100% | 0.1% | 2 |
7 | GRP GYNECOLOGISTS OBSTETRICIANS GENEVA | 1 | 100% | 0.1% | 2 |
8 | TEACHING HOSP GYNAECOL OBSTET | 1 | 100% | 0.1% | 2 |
9 | ARCADES | 1 | 40% | 0.1% | 2 |
10 | DISCIPLINE GYNECOL | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215023 | WOMENS HEALTH INITIATIVE//INTERDISCIPLINARY GRP OSTEOPOROSIS//WHI STUDY |
2 | 0.0000193073 | REPRODUCTIVE FACTORS//AGE AT FIRST FULL TERM PREGNANCY//AGE AT LAST BIRTH |
3 | 0.0000159627 | ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7 |
4 | 0.0000154778 | TIBOLONE//TIBOLONE METABOLITES//LIVIAL |
5 | 0.0000145837 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//MAMMOGRAPHIC BREAST DENSITY |
6 | 0.0000121584 | MOLECULAR APOCRINE//DAME ROMA MITCHELL CANC S//ESTROGEN RECEPTOR NEGATIVE |
7 | 0.0000113903 | CEITOX//BREAST CELL CARCINOGENESIS//POL III GENES |
8 | 0.0000110663 | PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A |
9 | 0.0000097117 | FERTILITY DRUGS//OVARIAN NEOPLASMS//INCESSANT OVULATION |
10 | 0.0000091939 | HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS |